Resić Halima, Corić Aida, Dedeić-Ljubović Amela, Hukić Mirsada, Avdić Emir, Kukavica Nihad
Centar za hemodijalizu, Klinicki centar Univerziteta, Sarajevo.
Med Pregl. 2007;60 Suppl 2:97-100.
The prevalence of MRSA (Methicillin Resistant Staphylococcus Aureus) in haemodialysis patients has increased dramatically during recent years. The aim of our study is to determine the prevalence of MRSA colonization among haemodialysis patients and medical staff.
This prospective study included 235 patients undergoing haemodialysis therapy and 60 medical staff members, in the Center for Haemodialysis Sarajevo. Nasal and throat samples were taken (identification of MRSA was performed using standard microbiological methods). A total of 474 nasal and throat cultures from patients' samples and 120 cultures from medical staff samples were obtained.
The total number of sampled patients was 235 and colonies were found in 36 of the samples (15.3%). Among medical staff nasal carriage rate of MRSA was 11.6% (7/60). The mean age of haemodialysis patients with MRSA was 52.94:1:5.3. The patients aged between 55 and 64 had the highest prevalence of MRSA (11/36, 30.55%). Those aged 45-54 had the next highest prevalence of nasal carriage (10/36, 27.77%). Patients aged 65 years had middle prevalence of MRSA (6/36, 8.33%). Patients aged 25-34 had the lowest prevalence of nasal carriage. We did not have possibilities to isolate MRSA positive dialysis patients, and we used intensive antibacterial prophylaxis. We treated our patients with mupirocin ointment (three times a day for 5-14 days) and gained decolonization in 34 patients (94.4%). In the treatment period, positive medical staff did not come to work.
The overall prevalence of MRSA colonization in our dialysis patients was higher (15.3%). Implementation of adequate strategies for prevention of MRSA with application of mupirocin among carriers, reduced prevalence of MRSA in our dialysis units.
近年来,血液透析患者中耐甲氧西林金黄色葡萄球菌(MRSA)的患病率急剧上升。我们研究的目的是确定血液透析患者和医护人员中MRSA定植的患病率。
这项前瞻性研究纳入了萨拉热窝血液透析中心的235例接受血液透析治疗的患者和60名医护人员。采集了鼻腔和咽喉样本(使用标准微生物学方法进行MRSA鉴定)。共获得474份患者样本的鼻腔和咽喉培养物以及120份医护人员样本的培养物。
采样患者总数为235例,其中36份样本中发现菌落(15.3%)。医护人员中MRSA的鼻腔携带率为11.6%(7/60)。携带MRSA的血液透析患者的平均年龄为52.94±5.3岁。年龄在55至64岁之间的患者MRSA患病率最高(11/36,30.55%)。年龄在45至54岁之间的患者鼻腔携带率次之(10/36,27.77%)。65岁的患者MRSA患病率中等(6/36,8.33%)。年龄在25至34岁之间的患者鼻腔携带率最低。我们没有分离出MRSA阳性的透析患者,因此使用了强化抗菌预防措施。我们用莫匹罗星软膏治疗患者(每天三次,持续5至14天),34例患者(94.4%)实现了去定植。在治疗期间,阳性的医护人员未上班。
我们透析患者中MRSA定植的总体患病率较高(15.3%)。通过对携带者应用莫匹罗星实施适当的MRSA预防策略,降低了我们透析单位中MRSA的患病率。